The U.S. Army Medical Research Institute together with Dr. R. Newman (PBI Chief Science Officer) presented research with PBI’s oleander extract at the 9th International Symposium on Filoviruses held in Marburg, Germany.

2023-12-19T03:38:38-06:00
Comments Off on The U.S. Army Medical Research Institute together with Dr. R. Newman (PBI Chief Science Officer) presented research with PBI’s oleander extract at the 9th International Symposium on Filoviruses held in Marburg, Germany.

Dual activities of the anti-cancer drug candidate PBI-05204 provide neuroprotection in brain slice models for neurodegenerative diseases and stroke

2023-12-04T17:18:01-06:00
Comments Off on Dual activities of the anti-cancer drug candidate PBI-05204 provide neuroprotection in brain slice models for neurodegenerative diseases and stroke

PBI is pleased to announce an excellent rate of accrual of advanced pancreatic cancer patients to their Phase II clinical study.

2023-12-04T17:18:06-06:00
Comments Off on PBI is pleased to announce an excellent rate of accrual of advanced pancreatic cancer patients to their Phase II clinical study.

Research with colleagues at Duke University continues to reveal important brain mediated benefits in response to PBI-05204.

2023-12-04T17:18:11-06:00
Comments Off on Research with colleagues at Duke University continues to reveal important brain mediated benefits in response to PBI-05204.

NIH has expressed an interest in exploring the potential of PBI-05204 to alleviate the extreme fatigue often associated in cancer patients undergoing radiation therapy.

2023-12-04T17:18:15-06:00
Comments Off on NIH has expressed an interest in exploring the potential of PBI-05204 to alleviate the extreme fatigue often associated in cancer patients undergoing radiation therapy.

Antioxidant, anti-inflammatory, anti-apoptotic, and skin regenerative properties of an Aloe vera-based extract of Nerium oleander leaves

2024-01-24T13:48:55-06:00
Comments Off on Antioxidant, anti-inflammatory, anti-apoptotic, and skin regenerative properties of an Aloe vera-based extract of Nerium oleander leaves

In late December, 2014 the FDA approved of our plans to take PBI-05204 forward into clinical Phase II trials.

2023-12-04T17:18:19-06:00
Comments Off on In late December, 2014 the FDA approved of our plans to take PBI-05204 forward into clinical Phase II trials.
Go to Top